Budget77

The intervention by the Japanese government and the Bank of Japan appears to have taken place on Thursday, April 30, 2024, and continued into Friday, May 1, 2026. This move, which market participants estimate involved approximately 5 to 6 trillion yen ($32.00US to $38.00US billion), was a decisive attempt to protect the yen as it breached the critical 160.00 level against the US dollar.  This intervention is a major "stress test" for the global yen carry trade. Because investors borrow cheap yen to buy higher-yielding assets—including tech stocks, the S&P 500, and commodities—a sudden surge in the yen's value often triggers a "margin call" on these positions.

@probzunknown In federal diplomacy and trade, a high-ranking official's direct participation serves a deliberate strategic purpose. This specific alignment carries substantial meaning across several key areas.

$AREC: Here are some more pics of the signing ceremony this past week between ReElement and POSCO in DC. So awesome 👏 "Under Secretary William Kimmitt welcomed the POSCO International + ReElement Technologies $200M joint investment announcement to develop and secure rare earth supply chains in the United States 🪨⛓️. Thanks to President Trump's leadership, strong U.S.-Korea alliances are bringing groundbreaking investments into the United States in sectors vital to American security and prosperity." linkedin.com/feed/update/ur…

@jcmemeteam @elonmusk @kkwriter2 It’s coming!😢

@elonmusk @kkwriter2 Image the outcry if Disney remade Tarzan as a gay black man.

Exactly

@dayoneapp I had 27 years of daily journal entries kept in MS Windows program called @DavidRMJournal. I’ve tried for 10 years to convert those entries into a format to import into the DayOne journal. No luck. Finally I tried Anthropic Claude- it converted a 2,000 page txt file into a json.zip which imported into DayOne in about 10 seconds. It’s amazing to finally have a complete journal with daily dated entries in DayOne going all the way back to October 1989. @claudeai

Anthony, Linder & Cacomanolis, PLLC Always Evolving and Adapting ALCLAW.com Recent Notable Transactions Hycroft Mining Holding Corp. $100,000,000 At-The-Market (ATM) offering Issuer’s Counsel Click For More- bit.ly/48oOA1W #TeamALC #ALCLAW

Based on @Hycroft financial filings for the first quarter of 2026, here is the breakdown of who received the $34.2 million in G&A costs and the reasoning behind the "make-whole" payments. Who received the money? The majority of the $34.2 million was allocated to the company’s leadership team and key plan participants. Specifically: •Make-whole Awards ($24.1 million): These were issued to executives and certain plan participants. The most notable recipient was CEO Diane Garrett, who received a significant portion including a $4.53 million cash payment and 88,035 fully vested Restricted Stock Units (RSUs). •Extraordinary Cash Bonus ($4.5 million): This was a one-time "Bonus Pool" shared among the Named Executive Officers (NEOs)—including CEO Diane Garrett and CFO Stanton Rideout—and other key employees. What was the purpose of "Making Whole"? The company describes these as "Make-whole Awards" to address a deficit in executive pay from 2023 through 2025. •Restricted Share Availability: Between 2023 and 2025, Hycroft did not have enough shares available in its incentive plans to meet the "target" pay levels promised to executives. •Catch-up Payment: Because the executives received equity awards "substantially below" their target levels during those years, the Board used the new incentive plan (approved in late 2025) to pay them back for the missed value. •Immediate Vesting: To mimic the time that had already passed, a large portion of these awards vested immediately on January 27, 2026, resulting in the high cash and non-cash expense reported this quarter. Was there a conflict? While the company presents this as a necessary move to "align with target incentive opportunities" and retain leadership, it creates a potential point of friction for shareholders: •Timing of the "Success": The $4.5 million extraordinary bonus was specifically to reward the "transformational financings" of 2025. While these financings retired debt and left Hycroft with $189.0 million US in cash, critics often point out that such financings often involve significant shareholder dilution. •Exploration vs. Compensation: Hycroft is currently an exploration-stage company with no significant revenue. The $34.2 million in G&A costs is more than triple the $9.7 million spent on actual exploration and development during the same period. •Non-Recurring Claim: The Board labeled the $4.5 million US bonus as "non-recurring" to assure investors it won't happen every year, but the sheer size of the total package (nearly 10% of the quarterly net loss) is a frequent topic of debate in junior mining circles. AI generated response can be inaccurate or misleading. Do your own research and due diligence. Not recommended as trading advice.

$HYMC LMAO c'mon man, at least deliver a PEA with this. Guess who's paying for all this? 🫵🏻

Newmont divested six non-core assets throughout late 2025 and early 2026—including the Musselwhite, Éléonore, and Porcupine mines in Canada—Newmont effectively traded geographic "safety" for higher-margin production. While this move successfully lowered the company’s consolidated All-In Sustaining Costs (AISC), it significantly concentrated their financial health into a handful of massive Tier-1 districts, thereby magnifying the impact of regional political shifts. @DonDurrett @DonaldW60852684

$nem Newmont Corporation is experiencing a sharper decline than its mining peers as of April 27, 2026, currently trading around **$120.70US** despite a recent record-breaking earnings report. While the broader sector is pulled down by gold prices near **$4,705.10US**, Newmont faces unique pressure from a regulatory showdown in Ghana, where authorities have mandated a transition to local contractors by December 2026 and denied the company’s request for an extension. This situation creates significant operational and labor risk in a "core" jurisdiction that accounts for approximately **15% to 18%** of Newmont's total production and over **20%** of its free cash flow. Investors are pricing in the potential for higher costs and disruptions to high-margin assets like Ahafo North, especially as Newmont’s recent strategy of selling off non-core assets has increased its financial sensitivity to instability in its primary Tier-1 locations. AI generated response can be inaccurate or misleading. Do your own research and due diligence. Not recommended as trading advice. @formerlyaic

This post makes some accurate points but frames them misleadingly to build an anti-statin narrative. Here’s a balanced breakdown: What’s Actually True Brain cholesterol content: The ~25% figure is roughly accurate. The brain is indeed the most cholesterol-rich organ, and cholesterol is essential for myelin, synapses, and neuronal function. FDA label change (2012): True. The FDA did add cognitive side effect warnings based on post-market adverse event reports. Where It Gets Misleading The critical omission: Brain cholesterol is synthesized locally by astrocytes — it does not cross the blood-brain barrier. Statins have very limited BBB penetration, meaning systemic LDL reduction has minimal direct impact on brain cholesterol pools. This is the central flaw in the post’s implied logic. What the clinical evidence actually shows: •The HOPE-3 trial (17,000+ patients) found no cognitive decline with rosuvastatin over 5+ years •A Cochrane review of statin trials found no evidence of adverse cognitive effects in RCTs •Some observational studies actually suggest statins may be protective against dementia •The FDA label change was based on case reports, not controlled trials — a much weaker evidence standard Cognitive side effects in practice: They do occur in some individuals, are generally reversible on discontinuation, and appear rare in controlled studies (~1-2 per 10,000 patient-years) Bottom Line The post uses real facts selectively to imply statins are destroying brains — which isn’t supported by the controlled trial data. That said, statin side effects are real and worth discussing with your doctor, especially if you notice cognitive changes.

I carry a gene that raises my risk of Alzheimer's by 40%. It is called APOE ε4. About 25% of people carry at least one copy. I have one. My son David has the same one. Nobody told me until I was 53. After my heart attack. After 12 years of annual physicals. The test costs $100. Once. For life.

Eric Sprott did own shares in Chesapeake Gold prior to the 2020/2021 period when the company acquired the oxidative heap leach technology and associated rights from Hycroft Mining. In fact, Eric Sprott has been a cornerstone investor in Chesapeake Gold for well over a decade. His involvement dates back to at least 2010/2011, long before the "technology pivot" that characterizes the company today. During that earlier era, Chesapeake was primarily focused on the conventional (and very expensive) development of its massive Metates project in Mexico. Eric Sprott was already a major shareholder by 2011, holding roughly 15% of the company. At that time, the project was being modeled as a massive sulfide milling operation with a multi-billion dollar capital requirement. • In late 2020 and early 2021, Chesapeake Gold completed the acquisition of Alderley Gold, which held the rights to the proprietary oxidative heap leach technology. This technology was originally developed and proven at the Hycroft Mine in Nevada. • Continued Support: Since that acquisition, Sprott has consistently maintained or increased his position. As recently as January 2026, he participated in a $2.8 millionUS non-brokered private placement, and filings from April 2024 show he held roughly 13.1% of the company through his holding company, 2176423 Ontario Ltd.+1Currently, Sprott and Sun Valley Gold are reported to collectively own approximately 35% of the outstanding shares, providing the significant financial backing needed as the company moves Metates toward its Pre-Feasibility Study (PFS) in 2026.

Future Strategy: Licensing Beyond its own project, Chesapeake is pursuing a "technology company" model. They have identified over 200 refractory deposits globally where this technology could be applied. By owning the IP, they can now license the process to third-party miners, creating an additional revenue stream independent of their own production.

Project Economics and Valuation By switching to heap leaching, the projected capital cost for Metates has dropped from the billions into the hundreds of millions. Current estimates suggest a capital requirement of roughly $360.00US million to get the mine into production, targeting about 150,000 gold-equivalent ounces annually over a 30-year life. @Chesapeake_Gold

Proprietary Oxidation Technology The core of the "new" Chesapeake investment thesis is its proprietary heap oxidation technology. Historically, the Metates deposit was considered a "refractory" nightmare—meaning the gold is trapped inside sulfide minerals and cannot be recovered through simple leaching.  • The Old Way: Previous studies suggested building a massive autoclave (pressure oxidation) facility. This required a $3.60US billion capital expenditure, including a desalination plant and a long-distance water pipeline. • The New Way: Chesapeake acquired a proprietary chemical technology that allows them to oxidize the sulfide ore directly on a heap leach pad. This essentially speeds up the natural weathering process from decades to months.  • Recent Breakthrough: On April 23, 2026, the company announced it received a formal U.S. Patent (No. 12,595,529) for this enhanced metal recovery method.

Eric Sprott's Ownership As of early 2026, Eric Sprott continues to be the cornerstone institutional investor for Chesapeake Gold. Following a major financing round earlier this year, his beneficial ownership is approximately 17.9% of the outstanding common shares on a non-diluted basis. When including his warrants, that position rises to roughly 19.9% on a partially diluted basis. Collectively, Eric Sprott and Sun Valley Gold control approximately 35% of the company's equity, providing a very stable and supportive shareholder base.

@Chesapeake This patent is a critical component of their "lease rights" strategy, as it provides the legal protection necessary to license the technology to other miners facing similar refractory challenges. • Licensing Revenue Stream: Management has explicitly outlined plans to create a parallel revenue stream by licensing this technology. This is targeting a global refractory ore market estimated to be worth over $1.5 trillionUS. • Metates Economics: By using this oxidative leach technology instead of a traditional pressure oxidation (POX) plant, the capital expenditure (CAPEX) for the Metates project has been reduced from roughly $3.5 billionUS to approximately $360 millionUS. Technology Performance & Metrics The "lease-ready" status of the technology is supported by recent metallurgical results: • Recovery Rates: Test work has shown that gold recovery increases from a baseline of 33% (untreated) to approximately 74% after 204 days of oxidation. • Asset Scale: The Metates deposit itself remains one of the largest undeveloped precious metals endowments globally, containing over 16.77 million ounces of gold at 0.57 and 423.2 million ounces of silver at 14.3. • Recent Funding: To support the advancement of this IP and project development, the company closed a $17.2 millionUS bought deal and a $2.8 millionUS private placement involving Eric Sprott in early 2026. Chesapeake currently holds or has pending patents in 10 jurisdictions, including the U.S., Canada, Mexico, Australia, and several South American countries, positioning them to act as a technology provider for refractory projects worldwide.

As of April 24, 2026, Chesapeake Gold (CKG.V) is trading at $3.48US, marking a daily increase of roughly 5.45% following the patent news. The stock has seen a volatile but generally upward trend over the last month, recovering from lows near $2.60US in March. The company continues to advance its Pre-Feasibility Study (PFS) to further de-risk the Metates asset and is exploring other sulphide deposits where this patented technology could be applied.

Chesapeake Gold Receives a U.S. Patent for Enhanced Metal Recovery from Sulphide Ores by @newsfile @newsfile/chesapeake-gold-receives-a-us-patent-for-enhanced" target="_blank" rel="nofollow noopener">ceo.ca/@newsfile/ches… @DonDurrett

@Christalball93 ERIC owns 6.8 million unexercised warrants remaining as of April 2026 with an exercise price of $6.00. Brand new shares out of thin air. Fully dilutive to all stockholders when he exercises. Makes his open market purchases seem small.

$Hycroft Mining Holding Corp wonder if anyone dumb enough to sell Sprott hundreds of thousands of more shares?

@probzunknown Take a breath – the shorts will beat it back down.

$AREC: Did I miss something?? I needed more time to buy 😅